Fabry Disease

Fabry Disease is a rare genetic condition. It affects how your body breaks down certain fats, leading to a buildup in your blood vessels. This buildup causes problems in your kidneys, heart, brain, and skin over time.

ConditionRare Disease

What people with Fabry Disease report

Every report comes from a Lived member, sent anonymously.

Have you tried Enzyme Replacement Therapy for Fabry Disease?

NameHow it went

About Fabry Disease

What It Is

Fabry disease is an inherited condition in which the body cannot properly break down a fatty substance called globotriaosylceramide. Normally an enzyme called alpha-galactosidase A clears it inside cells. When that enzyme is missing or works poorly, the substance slowly builds up in the walls of small blood vessels and in the kidneys, heart and nerves, and the damage adds up over years. In the classic form, symptoms usually begin in childhood or the teen years. The most typical are episodes of burning pain in the hands and feet, reduced sweating with poor tolerance of heat and exercise, clusters of small dark red spots on the skin (angiokeratomas), stomach pain and diarrhea, and ringing in the ears or hearing loss. Over time, the build-up can lead to kidney disease, a thickened heart muscle with heart rhythm problems, and strokes. These later complications matter most for long-term health. Fabry disease varies widely. Some people have a later-onset form with an ordinary childhood, and the disease shows up in adulthood as heart, kidney or stroke problems. Women can be affected too, usually more mildly and later than men, though sometimes just as seriously. Because the early symptoms resemble many common problems, the diagnosis is often delayed for years, especially in women.

Causes & Risk Factors

Fabry disease is caused by changes (variants) in the GLA gene, which carries the instructions for making alpha-galactosidase A. Variants that leave almost no working enzyme usually cause the classic form. Variants that leave some activity usually cause the later-onset form. It is not caused by anything a person did. The GLA gene sits on the X chromosome, so inheritance follows sex. A father with Fabry disease passes the variant to all of his daughters and none of his sons. A mother with the variant has a 50% chance of passing it to each child. Men have only one X chromosome, so one altered copy causes the disease. Women have two, and how much each copy is used varies from organ to organ, which helps explain why women range from having no symptoms to being as affected as men. When one person is diagnosed, parents, siblings, children and other relatives may also carry the variant. In people who already have Fabry disease, pain episodes (sometimes called Fabry crises) can be set off by hot weather, exercise, fever, fatigue and stress. These are triggers for symptoms, not causes of the disease.

How It's Diagnosed

The diagnosis often starts with a recognizable combination: childhood burning pain with little sweating, or kidney disease, heart muscle thickening or a stroke with no clear explanation, especially at a younger age than expected. Often the trigger is a relative's diagnosis. An eye doctor may notice a swirl-shaped pattern of deposits on the cornea, the clear front surface of the eye. It does not affect vision, but it is a strong clue. Testing differs between men and women. In men, a blood test showing low alpha-galactosidase A activity strongly suggests Fabry disease, and testing the GLA gene confirms it and identifies the exact variant. In women, enzyme activity is often in the normal range even when the disease is present, so genetic testing is the only reliable way to confirm it. Sometimes testing finds a variant whose effect is uncertain. Specialists then look for direct evidence of the disease in the organs, occasionally with a small tissue sample (biopsy) from the kidney, heart or skin. Once Fabry disease is confirmed, a baseline check of each organ shows where things stand. This usually includes urine and blood tests of kidney function, an ECG (a recording of the heart's electrical activity), an echocardiogram (heart ultrasound) and often a heart MRI, which can show scarring in the heart muscle that makes treatment less effective, along with a brain MRI and eye and hearing exams. Genetic counseling is offered so that relatives at risk can decide whether to be tested.

Treatment Options

There is no cure for Fabry disease, but there are treatments that target the underlying enzyme problem, and they tend to work best when started before organs are badly damaged. Men with the classic form are generally advised to start treatment even before symptoms appear. For women and for people with the later-onset form, the decision usually depends on symptoms and signs of organ involvement, so the timing is more individual. Enzyme replacement therapy supplies a manufactured version of the missing enzyme through an intravenous infusion every two weeks. In the US, the options are agalsidase beta (Fabrazyme), approved for adults and children 2 years and older, and pegunigalsidase alfa (Elfabrio), approved for adults. Treatment can help stabilize kidney function, reduce heart muscle thickening and ease nerve pain. It works less well once extensive scarring has formed in the heart, and there is no clear evidence that it improves hearing. Infusion reactions such as chills, flushing or itching can occur and are often prevented with medicines given beforehand. Serious allergic reactions, including anaphylaxis, are uncommon but can be life-threatening, so infusions are started in a setting prepared to treat them. Migalastat (Galafold) is a capsule taken every other day that works differently. It is a chaperone medicine: it binds to a person's own faulty enzyme and helps it reach the part of the cell where it does its job. It only works for certain gene variants, called amenable variants, so it is approved for adults whose specific variant has tested as responsive in the laboratory. It must be taken on an empty stomach, with no food or caffeine for 2 hours before and after each dose, and it is not recommended for people with severe kidney impairment or on dialysis. It has been shown to clear the stored substance from kidney cells, but its benefit on long-term kidney, heart and stroke outcomes is still being confirmed, which is why its US approval is an accelerated one. Supportive care is an essential part of treatment alongside these therapies. Blood pressure medicines called ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers help protect the kidneys by reducing protein leakage into the urine, something enzyme therapy alone does not reliably do. These medicines are not used during pregnancy, so tell your care team if you are planning one. Nerve pain is treated with medicines used for nerve pain more generally, such as gabapentin or carbamazepine, alongside avoiding known triggers. Other care depends on which organs are involved: treatment for heart rhythm problems, blood thinners to prevent stroke if atrial fibrillation (an irregular heart rhythm) develops, cholesterol and blood pressure control, hearing aids, and dialysis or a kidney transplant if kidney failure develops.

What to Expect

Fabry disease is lifelong and usually progressive, but the pace varies greatly, even among relatives with the same variant. Before dialysis, kidney transplants and enzyme therapy were available, men with the classic form lived to about 40 on average. Outlook today depends a great deal on how early organ involvement is found and treated, and long-term results with current treatments are still being gathered. Day to day, the most common burdens are pain, fatigue, heat intolerance and digestive symptoms. Many people learn to plan around heat and strenuous exercise, keep cool, and have a plan for pain flares agreed with their care team. For people on enzyme replacement, infusions every two weeks become a regular part of life. Care is usually coordinated by a team experienced in Fabry disease, with regular monitoring: kidney tests about every 6 to 12 months, and heart, nervous system, eye and hearing checks about once a year. These checks catch changes before they cause symptoms and show whether treatment is working. Women with few symptoms still benefit from monitoring, because organ damage can develop quietly. Living with chronic pain and a rare diagnosis can also affect mood, and counseling, patient organizations and genetic counseling for family planning are part of good long-term care.

When to Seek Help

Ask about testing for Fabry disease if a relative has been diagnosed, or if you have a combination such as burning pain in the hands or feet, little or no sweating and heat intolerance, particularly alongside kidney, heart or stroke problems at a younger age than expected. If you already have Fabry disease, contact your care team when pain episodes become more frequent or harder to control, or when you notice new tiredness, swelling or breathlessness during ordinary activity. Contact your care team promptly about a fluttering, pounding or skipping heartbeat or dizziness. Sudden hearing loss or a sudden attack of severe vertigo (a spinning sensation) should be assessed the same day. Call 911 right away for signs of a stroke: sudden numbness or weakness of the face, arm or leg (especially on one side), sudden confusion or trouble speaking or understanding, sudden trouble seeing, or sudden loss of balance. Chest pain, severe shortness of breath or fainting (passing out) also needs emergency care.

Questions to Ask Your Doctor

  1. 1.Is my form of Fabry disease classic or later-onset, and what does my specific gene variant suggest about my outlook?
  2. 2.Which of my organs are affected now, and how often should each be checked?
  3. 3.Should I start enzyme replacement therapy now, and is my variant amenable to migalastat?
  4. 4.What can I do to prevent or manage pain episodes, and what should I do when one starts?
  5. 5.Which of my relatives should be offered genetic counseling and testing?

Last reviewed • Oct 2026

Educational content, not medical advice.